Speciality European Drug Patent Portfolio
Speciality European owns 1 orange book drug protected by 6 US patents Given below is the list of Speciality European's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5968895 | Pharmaceutical formulations for sustained drug delivery | 11 Dec, 2016 | Expired |
| US6180608 | Pharmaceutical formulations for sustained drug delivery | 11 Dec, 2016 | Expired |
| US6699833 | Pharmaceutical formulations for sustained drug delivery | 11 Dec, 2016 | Expired |
| US5843901 | LHRH antagonist peptides | 01 Dec, 2015 | Expired |
| US6423686 | LHRH antagonist peptides | 07 Jun, 2015 | Expired |
| US6455499 | Methods for treating disorders associated with LHRH activity | 07 Jun, 2015 | Expired |
Speciality European's Family Patents
Speciality European Drug List
Given below is the complete list of Speciality European's drugs and the patents protecting them.
1. Plenaxis
Plenaxis is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5968895 | Pharmaceutical formulations for sustained drug delivery |
11 Dec, 2016
(7 years ago)
| Expired |
| US6180608 | Pharmaceutical formulations for sustained drug delivery |
11 Dec, 2016
(7 years ago)
| Expired |
| US6699833 | Pharmaceutical formulations for sustained drug delivery |
11 Dec, 2016
(7 years ago)
| Expired |
| US5843901 | LHRH antagonist peptides |
01 Dec, 2015
(8 years ago)
| Expired |
| US6423686 | LHRH antagonist peptides |
07 Jun, 2015
(9 years ago)
| Expired |
| US6455499 | Methods for treating disorders associated with LHRH activity |
07 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Plenaxis's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List